Good presentation but still a while in it don't know about your $100-$200M in 12 months Massey ?
'14/'15/'16 and again represented in the presentation.
Look at the comparison companies they all have heavy cash backing, advanced / multiple candidates from Ph I through to III &/or big pharma partners to go with the cash.
ECQ looking at PhaseI 2H 2014 or 2015 depending on regulatory approval.
Good story but I still think not as fast as some are anticipating.
But there can always be black swans lurking so neatly tucked away :-)
ECQ Price at posting:
2.8¢ Sentiment: None Disclosure: Held